Charles A. Sanders, Director at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 3,333 shares at $27.73 ($92K) on 2008-05-20, disclosed to the SEC on 2008-05-21.
Scheduled sale ($92k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.46 | 333 | $9K | 9.9% |
| 2 | $27.47 | 334 | $9K | 10.0% |
| 3 | $27.50 | 334 | $9K | 10.0% |
| 4 | $27.58 | 333 | $9K | 10.0% |
| 5 | $27.59 | 333 | $9K | 10.0% |
| 6 | $27.61 | 333 |
| $9K |
| 10.0% |
| 7 | $27.67 | 333 | $9K | 10.0% |
| 8 | $27.71 | 667 | $18K | 20.1% |
| 9 | $27.73 | 333 | $9K | 10.0% |
| Total | $27.60 avg | 3,333 | $92K | 100% |
| Filing → |
| BIOD | BUY | 2011-08-11 | $12K | — | Filing → |
| BIOD | BUY | 2010-05-13 | $28K | — | Filing → |
| BCRX | BUY | 2010-02-09 | $33K | — | Filing → |